Open Access Open Access  Restricted Access Subscription Access

Unlocking the Potential of Nutraceuticals: A Critical Review of Their Impact on Human Health

Patil Divyashree Kantilal, Patil Bhagyshri S., Amitkumar R. Dhankani, Mansi A Dhankani, S. P. Pawar

Abstract


This review provides a comprehensive overview of nutraceuticals, their classification, and their potential health benefits. Coined by Dr. Stephen De Felice in 1989, nutraceuticals encompass food or food components that offer health advantages beyond basic nutrition. They play a crucial role in addressing various health issues, including obesity, heart disease, and cancer. Nutraceuticals span various industries, including food, herbal supplements, and pharmaceuticals, providing preventive and therapeutic benefits across a wide range of conditions. The classification of nutraceuticals includes established and potential categories, with examples provided for conditions they target, such as allergy relief, arthritis support, and cardiac diseases. Specific examples and benefits of various nutraceuticals, such as inorganic mineral supplements, vitamins, digestive enzymes, probiotics, prebiotics, antioxidants, dietary fibers, cereals and grains, health drinks, polyphenols, and polyunsaturated fatty acids (PUFAs), are outlined. Each category offers unique health benefits, highlighting the potential of nutraceuticals in enhancing health and preventing diseases through dietary interventions.


Full Text:

PDF

References


Dr.Zeeshan Afsar,Nutraceuticals, Essential of Herbal Drug Technology (Page No.31), by PV publications.

Adelaja AO, Schilling BJ. Nutraceutical: blurring the line between food and drugs in the twenty-first century. Mag Food Farm Resour Issues. 1999;14:35–40. [Google Scholar]

Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, Ma J. Blood levels of long-chain n-3 fatty acids and the risk of sudden death. New Engl J Med. 2002;346:1113–1118. doi: 10.1056/NEJMoa012918. [PubMed] [CrossRef] [Google Scholar]

Broughton KS, Johnson CS, Pace BK, Liebman M, Kleppinger KM. Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotriene production. Am J ClinNutr. 1997;65:1011–1017. [PubMed] [Google Scholar]

Brower V. Nutraceuticals: poised for a healthy slice of the healthcare market? Nat Biotechnol. 1998;16:728–731. doi: 10.1038/nbt0898-728. [PubMed] [CrossRef] [Google Scholar]

Buchner HC, Hengstler P, Schindler C, Meier G. N-3 polyunsaturated fatty acids in coronary heart disease—a meta analysis of randomized controlled trials. Am J Med. 2002;112:298–304. doi: 10.1016/S0002-9343(01)01114-7. [PubMed] [CrossRef] [Google Scholar]

Bull E. What is nutraceutical? Pharm J. 2000;265:57–58. [Google Scholar]

Calabrese JR, Rappor DJ, Shelton MD. Fish oils and bipolar disorder. Arch Gen Psychiatry. 1999;56:413–414. doi: 10.1001/archpsyc.56.5.413. [PubMed] [CrossRef] [Google Scholar]

Carlson SE. Long-chain polyunsaturated fatty acids and development of human infants. ActaPaediatr Suppl. 1999;88:72–77. doi: 10.1111/j.1651-2227.1999.tb01304.x. [PubMed] [CrossRef] [Google Scholar]

Connor WE. Importance of n-3 fatty acids in health and disease. Am J ClinNutr. 2000;71(suppl):171S–175S. [PubMed] [Google Scholar]


Refbacks

  • There are currently no refbacks.